Image via The Next Web (TNW)
Last updated
HistoSonics: Geographic Expansion
HistoSonics received regulatory approval from Taiwan's FDA for its Edison Histotripsy System, marking a significant step in expansion into Asia
Source: The Next Web (TNW)
The leadership read
Market entry of this kind typically deepens demand for medtech leadership bench strength in the region over the following 12–18 months.
Market context: The wider read — a Talent Market Index of 111.4 (Hot), up 5.2 month-on-month — shows Asia signal flow rising (+3.7pts).
HistoSonics: 1 signal in the last 90 days — in line with the MedTech median of 1 across 21 tracked companies; 0.1% of MitchelLake's Asia signal flow.
Market entry — the MitchelLake playbook
When a company expands into a new market, the first leadership hires decide whether it lands. A selection of market entries we've run:
Market entry · Oceania
Square
Executive Search Fintech
Market entry
Dropbox
Executive Search for SaaS
Market entry · Asia
Deliveroo
Executive Search in ASEAN
Market entry · Oceania
SurveyMonkey
Managing Director APAC (first hire in region) / Country Manager
Market entry · Asia
LivePerson
Director ASEAN (first hire in region); also Head of Presales APAC
Market entry · Oceania
Etsy
Managing Director, Australia + Asia (MD APAC)
MitchelLake in this thematic
More signals across MedTech
Geographic Expansion · Asia
Stryker →Stryker has established APAC operations with dedicated VP and General Manager role, indicating significant regional investment in medical technologies
Partnership · Asia
ZEISS Medical Technology →ZEISS Medical Technology signed a strategic agreement with Aier Eye Hospital Group for purchase and installation of 25 ZEISS VISUMAX 800 femtosecond lasers across multiple locations
Geographic Expansion · Oceania
Dedalus →Dedalus is expanding its diagnostic imaging portfolio into Australia and has appointed a senior business lead to drive the initiative
Partnership · Americas
Olympus Corporation →Olympus Corporation announced a 3-year reseller agreement in May 2026 making First Nation Group an authorized Service-Disabled Veteran-Owned Small Business reseller. This partnership provides federal healthcare providers streamlined access to Olympus capital equipment and single-use medical devices across gastroenterology, urology, respiratory and surgical specialties.
Leadership Change · Americas
Illumina →Illumina appoints Daniel M. Skovronsky, Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, to its Board of Directors, effective June 16, 2026.
Intelligence powered by Autonodal ↗